Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN   US75886F1075

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/16/2014 10/17/2014 10/20/2014 10/21/2014 10/22/2014 Date
340.71(c) 369.64(c) 366.125(c) 381.01(c) 375.42 Last
937 878 2 471 408 1 147 170 1 051 349 24 400 Volume
+1.78% +8.49% -0.95% +4.07% -1.47% Change
More quotes
Company
Regeneron Pharmaceuticals, Inc. operates as a biopharmaceutical company.It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.Regeneron markets medicines for eye diseases, colorectal cancer and a rare inflammatory condition and... 
Sector
Pharmaceuticals
Calendar
11/04Earnings Release
Surperformance© rating of Regeneron Pharmaceuticals
Trading Rating : Investor Rating :
More about the company
Chart REGENERON PHARMACEUTICALS
Duration : Period :
Regeneron Pharmaceuticals  Technical Analysis Chart | REGN | US75886F1075 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 2 806 M
EBIT 2014 1 124 M
Net income 2014 425 M
Finance 2014 1 134 M
Yield 2014 -
Sales 2015 3 484 M
EBIT 2015 1 553 M
Net income 2015 782 M
Finance 2015 2 355 M
Yield 2015 -
PER 2014 103,24
PER 2015 58,27
EV / Sales 2014 13,3x
EV / Sales 2015 10,4x
Capitalization 38 507 M
More Financials
Latest news on REGENERON PHARMACEUTICALS
1d ago SANOFI : and Regeneron Announce Start of Phase 3 Study of Dupilumab in Patients ..
1d ago REGENERON PHARMACEUTICALS : Earns Top Spot as Employer in the Global Biopharmace..
2d ago REGENERON PHARMACEUTICALS : and Sanofi Announce Start of Phase 3 Study of Dupilu..
3d ago REGENERON PHARMACEUTICALS : FDA OKs Eylea (aflibercept) Injection
5d ago REGENERON PHARMACEUTICALS : S&P 500 Analyst Moves: REGN
5d agoDJAmgen Files Patent Infringement Suit Over Cholesterol Drug
5d ago REGENERON PHARMACEUTICALS : EYLEA® (aflibercept) Injection Demonstrates Signific..
6d ago REGENERON PHARMACEUTICALS : Ranked Number One Biopharmaceutical Employer by Scie..
6d ago REGENERON PHARMACEUTICALS : Genetics Center Fully Operational, Announces New Col..
7d ago REGENERON PHARMACEUTICALS : New Findings from Regeneron Pharmaceuticals Inc in t..
7d ago REGENERON PHARMACEUTICALS : to Report Third Quarter 2014 Financial and Operating..
10/14 REGENERON PHARMACEUTICALS : Gets FDA OK for EYLEA (aflibercept) Injection for Ma..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF